The only additive you'll ever need

February 26, 2003

A SPOONFUL of sugar may no longer be needed to help the medicine go down- it could be replaced by natural compounds that block the taste of bitter substances.

The compounds could not only help drug companies make bitter-tasting medicines more palatable, they could also help food manufacturers reduce the vast amounts of sugar, salt and fat they add to most processed foods. Part of the reason these additives make food taste better is that they mask bitter tastes.

Biotech firm Linguagen of New York last month received patent protection for the family of blockers it has discovered, and it says there is already interest from food and drug companies. "A major food ingredient company is testing them, and a major pharmaceutical company," says chief operating officer Shawn Marcell.

"This has been a real breakthrough," says Linda Bartoshuk of Yale University, who studies taste perception. "For most of the stuff you hear out there, they almost never have data and they almost never publish anywhere reliable. But this is good solid science."

Linguagen was founded by Robert Margolskee of the Mount Sinai School of Medicine in New York, who discovered the particular cascade of reactions that leads to bitterness perception. When taste receptor cells in the mouth detect bitter compounds such as naringin, found in grapefruit, caffeine and the painkiller ibuprofen, they release a protein called gustducin (see Graphic). This triggers a series of reactions that finally results in a nerve impulse being sent to the brain saying "bitter".

Researchers at Linguagen tested a huge range of compounds from chemical libraries to see if any could block gustducin release. In test tubes they mixed the compounds one by one with a dye and the relevant components found in the mouth. When the dye turned blue, it signalled that gustducin had been produced. If it did not turn blue, the researchers assumed that the compound was blocking gustducin production. The team confirmed that the potential blockers really did prevent bitterness being perceived when lab mice could not distinguish a bitter solution doped with the blocker from plain water.

Then the researchers tried the best ones themselves, sipping coffee and grapefruit juice containing the compounds. Stephen Gravina, who carried out the experiments, said the coffee's flavour was "milder and more mellow".

Usefully, all the compounds that blocked bitterness are nucleotides, the family of molecules that includes the building blocks for DNA and RNA. All of them are naturally occurring and already found in various foods. That means the compounds will not require FDA approval when small amounts are added to food and drugs.

"We don't know exactly how it works," admits Gravina. But the researchers think that by bonding to the mouth's bitter taste receptors in place of the bitter compounds, they inhibit the release of gustducin.

Trying to block bitter flavours is far more practical than, say, trying to remove any of the vast range of compounds that can make food taste unpleasant. And only tiny amounts of bitter blockers are required to stop the bitter signal reaching the brain. The reason is evolutionary: some bitter substances are highly poisonous, so we need to detect compounds like them at very low concentrations.

If Linguagen's blockers are proven safe and effective, they could go a long way to making food healthier. At the moment, vast amounts of sugar, fat and salt, which are known to contribute to obesity, high blood pressure and the risk of strokes, are added to processed foods. One tin of soup can contain half the recommended daily intake of salt. Bitter blockers would avoid the need to mask unpleasant flavours and could also make bitter-tasting, healthy foods such as broccoli and soya more palatable.

Adding bitter blockers will not stop us detecting food that is rotten, adds Linguagen scientist Richard McGregor. Bad smells and sour tastes, conveyed to the brain through a different set of receptors and chemical messenger, warn us when food has gone off.

As well as working to develop more potent blockers to work in extremely bitter medicines, such as HIV drugs, Linguagen also hopes to tackle entirely different messengers and reaction pathways to produce artificial sweeteners and salt substitutes.
-end-
Written by Celeste Biever, Boston

New Scientist issue: 1 March 2003

PLEASE MENTION NEW SCIENTIST AS THE SOURCE OF THIS STORY AND, IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO: http://www.newscientist.com

"These articles are posted on this site to give advance access to other authorised media who may wish to quote extracts as part of fair dealing with this copyrighted material. Full attribution is required, and if publishing online a link to www.newscientist.com is also required. Advance permission is required before any and every reproduction of each article in full - please contact angela.bourton@rbi.co.uk. Please note that all material is copyright of Reed Business Information Limited and we reserve the right to take such action as we consider appropriate to protect such copyright."

UK CONTACT - Claire Bowles, New Scientist Press Office, London:
Tel: 44-207-331-2751 or email claire.bowles@rbi.co.uk
US CONTACT - Michelle Soucy, New Scientist Boston Office:
Tel: 617-558-4939 or email michelle.soucy@newscientist.com

New Scientist

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.